WASHINGTON, D.C. —  Congressman Mike Fitzpatrick (PA-8) sent the following letter to the Food and Drug Administration Tuesday regarding dramatic changes in the reporting of adverse events caused by the medical device Essure:

https://medium.com/@fitzpatrickpa8/fitzpatrick-questions-fda-about-essure-reporting-bed4b7ca7c74#.75mvy3v0n